Global and Region Nuclear Medicine & Radiopharmaceuticals Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Nuclear Medicine & Radiopharmaceuticals market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine & Radiopharmaceuticalsmarket, defines the market attractiveness level of Nuclear Medicine & Radiopharmaceuticals market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine & Radiopharmaceuticals industry, describes the types of Nuclear Medicine & Radiopharmaceuticals market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine & Radiopharmaceuticals market and the development prospects and opportunities of Nuclear Medicine & Radiopharmaceuticals industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine & Radiopharmaceuticals market in Chapter 13.

    By Player:

    • Triad Isotopes

    • Bracco Imaging

    • Dongcheng

    • SIEMENS

    • Bayer

    • Jubilant Pharma

    • Lantheus

    • Mallinckrodt

    • Navidea

    • IBA Group

    • GE Healthcare

    • Eli Lilly

    • Advanced Accelerator Applications

    • Nordion

    • China Isotope & Radiation

    By Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine & Radiopharmaceuticals Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine & Radiopharmaceuticals Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine & Radiopharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine & Radiopharmaceuticals Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine & Radiopharmaceuticals Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.4 China Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.6 India Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine & Radiopharmaceuticals Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine & Radiopharmaceuticals Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine & Radiopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine & Radiopharmaceuticals Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine & Radiopharmaceuticals Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine & Radiopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine & Radiopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine & Radiopharmaceuticals Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine & Radiopharmaceuticals Market Competitive Analysis

    • 14.1 Triad Isotopes

      • 14.1.1 Triad Isotopes Company Details

      • 14.1.2 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.2 Bracco Imaging

      • 14.2.1 Bracco Imaging Company Details

      • 14.2.2 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.3 Dongcheng

      • 14.3.1 Dongcheng Company Details

      • 14.3.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.4 SIEMENS

      • 14.4.1 SIEMENS Company Details

      • 14.4.2 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.5 Bayer

      • 14.5.1 Bayer Company Details

      • 14.5.2 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.6 Jubilant Pharma

      • 14.6.1 Jubilant Pharma Company Details

      • 14.6.2 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.7 Lantheus

      • 14.7.1 Lantheus Company Details

      • 14.7.2 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.8 Mallinckrodt

      • 14.8.1 Mallinckrodt Company Details

      • 14.8.2 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.9 Navidea

      • 14.9.1 Navidea Company Details

      • 14.9.2 Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Navidea Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.10 IBA Group

      • 14.10.1 IBA Group Company Details

      • 14.10.2 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.11 GE Healthcare

      • 14.11.1 GE Healthcare Company Details

      • 14.11.2 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.12 Eli Lilly

      • 14.12.1 Eli Lilly Company Details

      • 14.12.2 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.13 Advanced Accelerator Applications

      • 14.13.1 Advanced Accelerator Applications Company Details

      • 14.13.2 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.14 Nordion

      • 14.14.1 Nordion Company Details

      • 14.14.2 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Nordion Nuclear Medicine & Radiopharmaceuticals Product and Service

    • 14.15 China Isotope & Radiation

      • 14.15.1 China Isotope & Radiation Company Details

      • 14.15.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine & Radiopharmaceuticals

    • Figure Nuclear Medicine & Radiopharmaceuticals Picture

    • Table Global Nuclear Medicine & Radiopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine & Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine & Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine & Radiopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine & Radiopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    • Table Triad Isotopes (Foundation Year, Company Profile and etc.)

    • Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Bracco Imaging (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Dongcheng (Foundation Year, Company Profile and etc.)

    • Table Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table SIEMENS (Foundation Year, Company Profile and etc.)

    • Table SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Jubilant Pharma (Foundation Year, Company Profile and etc.)

    • Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Lantheus (Foundation Year, Company Profile and etc.)

    • Table Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Mallinckrodt (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Navidea (Foundation Year, Company Profile and etc.)

    • Table Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navidea Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table IBA Group (Foundation Year, Company Profile and etc.)

    • Table IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Advanced Accelerator Applications (Foundation Year, Company Profile and etc.)

    • Table Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table Nordion (Foundation Year, Company Profile and etc.)

    • Table Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Nuclear Medicine & Radiopharmaceuticals Product and Service

    • Table China Isotope & Radiation (Foundation Year, Company Profile and etc.)

    • Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.